CytoDyn Inc.

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, NONOF has a market cap of 320.7B. Regarding current trading prices, CYDY is priced at $0.30, while NONOF trades at $69.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas NONOF's P/E ratio is 19.58. In terms of profitability, CYDY's ROE is +0.07%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, CYDY is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NONOF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CSLLY has a market cap of 170.8B. Regarding current trading prices, CYDY is priced at $0.30, while CSLLY trades at $88.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CSLLY's P/E ratio is 32.29. In terms of profitability, CYDY's ROE is +0.07%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, CYDY is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CSLLY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CMXHF has a market cap of 85.1B. Regarding current trading prices, CYDY is priced at $0.30, while CMXHF trades at $175.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CMXHF's P/E ratio is 32.18. In terms of profitability, CYDY's ROE is +0.07%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, CYDY is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CMXHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, UCBJF has a market cap of 41.2B. Regarding current trading prices, CYDY is priced at $0.30, while UCBJF trades at $213.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas UCBJF's P/E ratio is 33.99. In terms of profitability, CYDY's ROE is +0.07%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, CYDY is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check UCBJF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, UCBJY has a market cap of 39.9B. Regarding current trading prices, CYDY is priced at $0.30, while UCBJY trades at $105.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas UCBJY's P/E ratio is 32.73. In terms of profitability, CYDY's ROE is +0.07%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, CYDY is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check UCBJY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, CYDY is priced at $0.30, while ARGNF trades at $547.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ARGNF's P/E ratio is 33.45. In terms of profitability, CYDY's ROE is +0.07%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, CYDY is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ARGNF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, CYDY is priced at $0.30, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ODTC's P/E ratio is 1.07. In terms of profitability, CYDY's ROE is +0.07%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, CYDY is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ODTC's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, IVBXF has a market cap of 19.7B. Regarding current trading prices, CYDY is priced at $0.30, while IVBXF trades at $11.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas IVBXF's P/E ratio is -1150.00. In terms of profitability, CYDY's ROE is +0.07%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, CYDY is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check IVBXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, WXIBF has a market cap of 16.3B. Regarding current trading prices, CYDY is priced at $0.30, while WXIBF trades at $4.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas WXIBF's P/E ratio is 36.36. In terms of profitability, CYDY's ROE is +0.07%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, CYDY is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check WXIBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, WXXWY has a market cap of 16.2B. Regarding current trading prices, CYDY is priced at $0.30, while WXXWY trades at $7.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas WXXWY's P/E ratio is 36.23. In terms of profitability, CYDY's ROE is +0.07%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, CYDY is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check WXXWY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, CYDY is priced at $0.30, while SBMFF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SBMFF's P/E ratio is 89.21. In terms of profitability, CYDY's ROE is +0.07%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, CYDY is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check SBMFF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SBHMY has a market cap of 15.6B. Regarding current trading prices, CYDY is priced at $0.30, while SBHMY trades at $17.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SBHMY's P/E ratio is 60.34. In terms of profitability, CYDY's ROE is +0.07%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, CYDY is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check SBHMY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, GNMSF has a market cap of 14B. Regarding current trading prices, CYDY is priced at $0.30, while GNMSF trades at $226.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas GNMSF's P/E ratio is 13.32. In terms of profitability, CYDY's ROE is +0.07%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, CYDY is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check GNMSF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, TRSBF has a market cap of 8.8B. Regarding current trading prices, CYDY is priced at $0.30, while TRSBF trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas TRSBF's P/E ratio is 31.00. In terms of profitability, CYDY's ROE is +0.07%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, CYDY is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check TRSBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, AKBLF has a market cap of 6.8B. Regarding current trading prices, CYDY is priced at $0.30, while AKBLF trades at $30.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas AKBLF's P/E ratio is 46.83. In terms of profitability, CYDY's ROE is +0.07%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, CYDY is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check AKBLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, CYDY is priced at $0.30, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, CYDY's ROE is +0.07%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, CYDY is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ABCZF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, GNNSF has a market cap of 5B. Regarding current trading prices, CYDY is priced at $0.30, while GNNSF trades at $2.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas GNNSF's P/E ratio is -28.83. In terms of profitability, CYDY's ROE is +0.07%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, CYDY is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check GNNSF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, CYDY is priced at $0.30, while INCPF trades at $3.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas INCPF's P/E ratio is -108.67. In terms of profitability, CYDY's ROE is +0.07%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, CYDY is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check INCPF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, CYDY is priced at $0.30, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas LABFF's P/E ratio is 28.95. In terms of profitability, CYDY's ROE is +0.07%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, CYDY is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check LABFF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, CYDY is priced at $0.30, while TLPPF trades at $13.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas TLPPF's P/E ratio is 150.00. In terms of profitability, CYDY's ROE is +0.07%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, CYDY is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check TLPPF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, AAVXF has a market cap of 4.4B. Regarding current trading prices, CYDY is priced at $0.30, while AAVXF trades at $68.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas AAVXF's P/E ratio is -19.88. In terms of profitability, CYDY's ROE is +0.07%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, CYDY is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check AAVXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ZLDPF has a market cap of 4.3B. Regarding current trading prices, CYDY is priced at $0.30, while ZLDPF trades at $61.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ZLDPF's P/E ratio is -22.70. In terms of profitability, CYDY's ROE is +0.07%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, CYDY is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ZLDPF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CAMRF has a market cap of 4.2B. Regarding current trading prices, CYDY is priced at $0.30, while CAMRF trades at $71.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CAMRF's P/E ratio is 56.35. In terms of profitability, CYDY's ROE is +0.07%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, CYDY is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check CAMRF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SHJBF has a market cap of 3.1B. Regarding current trading prices, CYDY is priced at $0.30, while SHJBF trades at $1.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, CYDY's ROE is +0.07%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, CYDY is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check SHJBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, CYDY is priced at $0.30, while REGMF trades at $5.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas REGMF's P/E ratio is -13.32. In terms of profitability, CYDY's ROE is +0.07%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, CYDY is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check REGMF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BVNRY has a market cap of 2.8B. Regarding current trading prices, CYDY is priced at $0.30, while BVNRY trades at $12.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BVNRY's P/E ratio is 13.83. In terms of profitability, CYDY's ROE is +0.07%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, CYDY is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BVNRY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BVNKF has a market cap of 2.8B. Regarding current trading prices, CYDY is priced at $0.30, while BVNKF trades at $36.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BVNKF's P/E ratio is 13.85. In terms of profitability, CYDY's ROE is +0.07%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, CYDY is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BVNKF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, CYDY is priced at $0.30, while TKBIF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, CYDY's ROE is +0.07%, compared to TKBIF's ROE of N/A. Regarding short-term risk, CYDY is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check TKBIF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, CYDY is priced at $0.30, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, CYDY's ROE is +0.07%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, CYDY is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check MPSYF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, CYDY is priced at $0.30, while ONTTF trades at $2.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ONTTF's P/E ratio is -12.78. In terms of profitability, CYDY's ROE is +0.07%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, CYDY is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check ONTTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, CYDY is priced at $0.30, while ASPHF trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, CYDY's ROE is +0.07%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, CYDY is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ASPHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, CYDY is priced at $0.30, while IUGNF trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, CYDY's ROE is +0.07%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, CYDY is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check IUGNF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, CYDY is priced at $0.30, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, CYDY's ROE is +0.07%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, CYDY is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BTTAY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, CYDY is priced at $0.30, while GLPGF trades at $28.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas GLPGF's P/E ratio is -5.57. In terms of profitability, CYDY's ROE is +0.07%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, CYDY is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check GLPGF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, CYDY is priced at $0.30, while BRCTF trades at $19.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BRCTF's P/E ratio is 18.07. In terms of profitability, CYDY's ROE is +0.07%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, CYDY is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BRCTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, CYDY is priced at $0.30, while GENSF trades at $26.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas GENSF's P/E ratio is -325.12. In terms of profitability, CYDY's ROE is +0.07%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, CYDY is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check GENSF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, CYDY is priced at $0.30, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BIESF's P/E ratio is -44.44. In terms of profitability, CYDY's ROE is +0.07%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, CYDY is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BIESF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, CYDY is priced at $0.30, while PHMMF trades at $92.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PHMMF's P/E ratio is 70.13. In terms of profitability, CYDY's ROE is +0.07%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, CYDY is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check PHMMF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, CYDY is priced at $0.30, while PPTDF trades at $11.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PPTDF's P/E ratio is 15.52. In terms of profitability, CYDY's ROE is +0.07%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, CYDY is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check PPTDF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CSBTF has a market cap of 1.4B. Regarding current trading prices, CYDY is priced at $0.30, while CSBTF trades at $36.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CSBTF's P/E ratio is -277.15. In terms of profitability, CYDY's ROE is +0.07%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, CYDY is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CSBTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, CYDY is priced at $0.30, while NURPF trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas NURPF's P/E ratio is 15.49. In terms of profitability, CYDY's ROE is +0.07%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, CYDY is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NURPF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, CYDY is priced at $0.30, while ASCLF trades at $1.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, CYDY's ROE is +0.07%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, CYDY is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check ASCLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, CYDY is priced at $0.30, while BRAXF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, CYDY's ROE is +0.07%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, CYDY is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check BRAXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, CYDY is priced at $0.30, while MEOBF trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, CYDY's ROE is +0.07%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, CYDY is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check MEOBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, CYDY is priced at $0.30, while SNBIF trades at $14.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SNBIF's P/E ratio is -34.83. In terms of profitability, CYDY's ROE is +0.07%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, CYDY is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check SNBIF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, CYDY is priced at $0.30, while HBMHF trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, CYDY's ROE is +0.07%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, CYDY is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check HBMHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CSPHF has a market cap of 910.9M. Regarding current trading prices, CYDY is priced at $0.30, while CSPHF trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CSPHF's P/E ratio is -62.50. In terms of profitability, CYDY's ROE is +0.07%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, CYDY is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check CSPHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PHGUF has a market cap of 787.9M. Regarding current trading prices, CYDY is priced at $0.30, while PHGUF trades at $1.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, CYDY's ROE is +0.07%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, CYDY is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PHGUF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BPMUF has a market cap of 752.8M. Regarding current trading prices, CYDY is priced at $0.30, while BPMUF trades at $61.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BPMUF's P/E ratio is 8.39. In terms of profitability, CYDY's ROE is +0.07%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, CYDY is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check BPMUF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, IDRSF has a market cap of 732.9M. Regarding current trading prices, CYDY is priced at $0.30, while IDRSF trades at $3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas IDRSF's P/E ratio is -2.12. In terms of profitability, CYDY's ROE is +0.07%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, CYDY is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check IDRSF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, INRLF has a market cap of 654.7M. Regarding current trading prices, CYDY is priced at $0.30, while INRLF trades at $3.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas INRLF's P/E ratio is -5.92. In terms of profitability, CYDY's ROE is +0.07%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, CYDY is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check INRLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SOLTF has a market cap of 556.5M. Regarding current trading prices, CYDY is priced at $0.30, while SOLTF trades at $6.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SOLTF's P/E ratio is -34.17. In terms of profitability, CYDY's ROE is +0.07%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, CYDY is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check SOLTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CKDXF has a market cap of 486.7M. Regarding current trading prices, CYDY is priced at $0.30, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, CYDY's ROE is +0.07%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, CYDY is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check CKDXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, CYDY is priced at $0.30, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas RAONF's P/E ratio is -43.33. In terms of profitability, CYDY's ROE is +0.07%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, CYDY is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check RAONF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, CYDY is priced at $0.30, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, CYDY's ROE is +0.07%, compared to TBGNF's ROE of N/A. Regarding short-term risk, CYDY is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check TBGNF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PTCHF has a market cap of 425.2M. Regarding current trading prices, CYDY is priced at $0.30, while PTCHF trades at $1.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, CYDY's ROE is +0.07%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, CYDY is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PTCHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, CYDY is priced at $0.30, while CLVLF trades at $8.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CLVLF's P/E ratio is 16.00. In terms of profitability, CYDY's ROE is +0.07%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, CYDY is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CLVLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, VBIZF has a market cap of 393.2M. Regarding current trading prices, CYDY is priced at $0.30, while VBIZF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas VBIZF's P/E ratio is 18.90. In terms of profitability, CYDY's ROE is +0.07%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, CYDY is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check VBIZF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CLVLY has a market cap of 388.5M. Regarding current trading prices, CYDY is priced at $0.30, while CLVLY trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CLVLY's P/E ratio is 15.50. In terms of profitability, CYDY's ROE is +0.07%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, CYDY is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CLVLY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CLTEF has a market cap of 387.7M. Regarding current trading prices, CYDY is priced at $0.30, while CLTEF trades at $5.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CLTEF's P/E ratio is -5.42. In terms of profitability, CYDY's ROE is +0.07%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, CYDY is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check CLTEF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, NWBO has a market cap of 377.6M. Regarding current trading prices, CYDY is priced at $0.30, while NWBO trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas NWBO's P/E ratio is -4.32. In terms of profitability, CYDY's ROE is +0.07%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, CYDY is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NWBO's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, HLOSF has a market cap of 376M. Regarding current trading prices, CYDY is priced at $0.30, while HLOSF trades at $3.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas HLOSF's P/E ratio is -11.08. In terms of profitability, CYDY's ROE is +0.07%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, CYDY is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check HLOSF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, CYDY is priced at $0.30, while IVEVF trades at $2.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, CYDY's ROE is +0.07%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, CYDY is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check IVEVF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, CYDY is priced at $0.30, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, CYDY's ROE is +0.07%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, CYDY is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PBBIF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, CYDY is priced at $0.30, while PRRUF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, CYDY's ROE is +0.07%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, CYDY is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PRRUF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BXPHF has a market cap of 277.1M. Regarding current trading prices, CYDY is priced at $0.30, while BXPHF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BXPHF's P/E ratio is -14.13. In terms of profitability, CYDY's ROE is +0.07%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, CYDY is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BXPHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, CYDY is priced at $0.30, while ORYZF trades at $3.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, CYDY's ROE is +0.07%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, CYDY is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ORYZF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, AVCTF has a market cap of 246.5M. Regarding current trading prices, CYDY is priced at $0.30, while AVCTF trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas AVCTF's P/E ratio is -5.79. In terms of profitability, CYDY's ROE is +0.07%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, CYDY is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check AVCTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, CYDY is priced at $0.30, while HNSBF trades at $2.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas HNSBF's P/E ratio is -3.04. In terms of profitability, CYDY's ROE is +0.07%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, CYDY is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check HNSBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, CYDY is priced at $0.30, while NWPHF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas NWPHF's P/E ratio is N/A. In terms of profitability, CYDY's ROE is +0.07%, compared to NWPHF's ROE of N/A. Regarding short-term risk, CYDY is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NWPHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, MDCLF has a market cap of 230.8M. Regarding current trading prices, CYDY is priced at $0.30, while MDCLF trades at $6.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, CYDY's ROE is +0.07%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, CYDY is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check MDCLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, CYDY is priced at $0.30, while SLNCF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, CYDY's ROE is +0.07%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, CYDY is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check SLNCF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, CYDY is priced at $0.30, while BOVNF trades at $3.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, CYDY's ROE is +0.07%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, CYDY is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check BOVNF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, CYDY is priced at $0.30, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, CYDY's ROE is +0.07%, compared to FPHAF's ROE of N/A. Regarding short-term risk, CYDY is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check FPHAF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, CYDY is priced at $0.30, while VSBC trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas VSBC's P/E ratio is N/A. In terms of profitability, CYDY's ROE is +0.07%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, CYDY is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check VSBC's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, CYDY is priced at $0.30, while FGHQF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, CYDY's ROE is +0.07%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, CYDY is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check FGHQF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CAIHF has a market cap of 204.9M. Regarding current trading prices, CYDY is priced at $0.30, while CAIHF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CAIHF's P/E ratio is 7.00. In terms of profitability, CYDY's ROE is +0.07%, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, CYDY is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check CAIHF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BSEM has a market cap of 192.8M. Regarding current trading prices, CYDY is priced at $0.30, while BSEM trades at $11.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BSEM's P/E ratio is 8.03. In terms of profitability, CYDY's ROE is +0.07%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, CYDY is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BSEM's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SPHDF has a market cap of 190.7M. Regarding current trading prices, CYDY is priced at $0.30, while SPHDF trades at $14.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SPHDF's P/E ratio is -3.19. In terms of profitability, CYDY's ROE is +0.07%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, CYDY is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check SPHDF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, NGENF has a market cap of 186.6M. Regarding current trading prices, CYDY is priced at $0.30, while NGENF trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas NGENF's P/E ratio is -9.14. In terms of profitability, CYDY's ROE is +0.07%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, CYDY is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check NGENF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, CMVLF has a market cap of 186M. Regarding current trading prices, CYDY is priced at $0.30, while CMVLF trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas CMVLF's P/E ratio is -3.85. In terms of profitability, CYDY's ROE is +0.07%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, CYDY is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check CMVLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, CYDY is priced at $0.30, while GNFTF trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas GNFTF's P/E ratio is 93.00. In terms of profitability, CYDY's ROE is +0.07%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, CYDY is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check GNFTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, CYDY is priced at $0.30, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, CYDY's ROE is +0.07%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, CYDY is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ADOCY's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, CYDY is priced at $0.30, while BRIBF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, CYDY's ROE is +0.07%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, CYDY is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check BRIBF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, CYDY is priced at $0.30, while OPORF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas OPORF's P/E ratio is 12.00. In terms of profitability, CYDY's ROE is +0.07%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, CYDY is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check OPORF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, CYDY is priced at $0.30, while MLLCF trades at $4.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, CYDY's ROE is +0.07%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, CYDY is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check MLLCF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, SCNLF has a market cap of 135.4M. Regarding current trading prices, CYDY is priced at $0.30, while SCNLF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, CYDY's ROE is +0.07%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, CYDY is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check SCNLF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, CYDY is priced at $0.30, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas AAPGV's P/E ratio is N/A. In terms of profitability, CYDY's ROE is +0.07%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, CYDY is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check AAPGV's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, CYDY is priced at $0.30, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, CYDY's ROE is +0.07%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, CYDY is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check AMGXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, IPHYF has a market cap of 120.7M. Regarding current trading prices, CYDY is priced at $0.30, while IPHYF trades at $1.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas IPHYF's P/E ratio is -1.82. In terms of profitability, CYDY's ROE is +0.07%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, CYDY is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check IPHYF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, CYDY is priced at $0.30, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, CYDY's ROE is +0.07%, compared to PSTTF's ROE of N/A. Regarding short-term risk, CYDY is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check PSTTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, CYDY is priced at $0.30, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, CYDY's ROE is +0.07%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, CYDY is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check EPRXF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, CYDY is priced at $0.30, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, CYDY's ROE is +0.07%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, CYDY is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check ADOIF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, CYDY is priced at $0.30, while JWCTF trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, CYDY's ROE is +0.07%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, CYDY is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for CYDY.Check JWCTF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, TRGNF has a market cap of 92.7M. Regarding current trading prices, CYDY is priced at $0.30, while TRGNF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, CYDY's ROE is +0.07%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, CYDY is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check TRGNF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PBIGF has a market cap of 90.9M. Regarding current trading prices, CYDY is priced at $0.30, while PBIGF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PBIGF's P/E ratio is -7.62. In terms of profitability, CYDY's ROE is +0.07%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, CYDY is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PBIGF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, CYDY is priced at $0.30, while MCURF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas MCURF's P/E ratio is -16.90. In terms of profitability, CYDY's ROE is +0.07%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, CYDY is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check MCURF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, ATGGF has a market cap of 79.4M. Regarding current trading prices, CYDY is priced at $0.30, while ATGGF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas ATGGF's P/E ratio is N/A. In terms of profitability, CYDY's ROE is +0.07%, compared to ATGGF's ROE of -0.76%. Regarding short-term risk, CYDY is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check ATGGF's competition here

CYDY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDY stands at 367.9M. In comparison, PRNAF has a market cap of 79M. Regarding current trading prices, CYDY is priced at $0.30, while PRNAF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDY currently has a P/E ratio of -14.92, whereas PRNAF's P/E ratio is -0.30. In terms of profitability, CYDY's ROE is +0.07%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, CYDY is less volatile compared to PRNAF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDY.Check PRNAF's competition here